KL

Ka-Man Venus Lai

RP Regeneron Pharmaceuticals: 10 patents #6 of 166Top 4%
📍 Seattle, WA: #55 of 4,728 inventorsTop 2%
🗺 Washington: #202 of 14,738 inventorsTop 2%
Overall (2019): #8,743 of 560,194Top 2%
10
Patents 2019

Issued Patents 2019

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
10457960 Methods and compositions for targeted genetic modification using paired guide RNAs David Frendewey, Wojtek Auerbach, Gustavo Droguett, Anthony Gagliardi, David M. Valenzuela +4 more 2019-10-29
10412939 Rodent model of prostate cancer Chia-Jen Siao, Hoi-Ching Lee, Zhe Li, Gavin Thurston 2019-09-17
10390522 Non-human animals having a humanized programmed cell death 1 gene Elena Burova, Alexander O. Mujica, Andrew J. Murphy 2019-08-27
10385359 Targeted modification of rat genome Jeffrey D. Lee, Alexander O. Mujica, Wojtek Auerbach, David M. Valenzuela, George D. Yancopoulos 2019-08-20
10329582 Genetic modification of rats Jeffrey D. Lee, Wojtek Auerbach, David Heslin, David Frendewey, David M. Valenzuela 2019-06-25
10301646 Nuclease-mediated targeting with large targeting vectors David Frendewey, Wojtek Auerbach, David M. Valenzuela, George D. Yancopoulos 2019-05-28
10285388 Non-human animals having a disruption in a C9ORF72 locus Amanda Atanasio, Burcin Ikiz, Guochun Gong, Michael L. LaCroix-Fralish, David M. Valenzuela 2019-05-14
10273488 Nuclease-mediated DNA assembly Chris Schoenherr, John McWhirter, Corey Momont, Caitlin Montagna, Lynn Macdonald +4 more 2019-04-30
10208317 Methods and compositions for the targeted modification of a mouse embryonic stem cell genome David Frendewey, Wojtek Auerbach, David M. Valenzuela, George D. Yancopoulos 2019-02-19
10196613 Stem cells for modeling type 2 diabetes Guochun Gong, David M. Valenzuela 2019-02-05